<p>Sutha Satkunarajah is the program director for Flagship Pioneering's Preemptive Health &amp; Medicine Initiative and is the head of project management at Apriori Bio. In his role at Flagship Pioneering, he is responsible for coordinating Flagship’s efforts to originate and grow a new generation of companies aimed at preempting novel pathogens and chronic diseases. Before joining Flagship, Sutha led the PMO of REACT, the UK’s COVID-19 surveillance program. Prior to this, Sutha was a principal at Carnall Farrar, where he led major transformation programs across several accountable care footprints. He spent his early career as an analyst at Oliver Wyman and at HgCapital, a European private equity firm. Sutha graduated from Harvard College with a BA in Cognitive Science.</p>

large_Sutha-New.jpg

Sutha Satkunarajah

Head of Project Management, Apriori Bio

Program Director, Preemptive Health & Medicine Initiative, Flagship Pioneering